Forecast: Production of Basic Pharmaceutical Products and Pharmaceutical Preparations in Sweden

The production of Basic Pharmaceutical Products and Pharmaceutical Preparations in Sweden has exhibited notable fluctuations over the past decade. With 2023 standing at 79.79 Billion SEK, the industry saw a peak production value of 88.05 Billion SEK in 2021, a significant leap considering the low of 66.54 Billion SEK in 2020. This rebound may have been influenced by increased pharmaceutical demand due to the COVID-19 pandemic. The period from 2017 to 2023 experienced a compound annual growth rate (CAGR) of -0.53%, indicating a slight downward trend in production value overall.

Future forecasts indicate a marginal decline, with the production value gradually decreasing to 79.61 Billion SEK by 2028. The forecasted average annual decline (CAGR) of -0.15% from 2024 to 2028 highlights a stable yet slightly reduced production outlook. The predicted five-year growth rate is -0.76%, signifying a small but continuous contraction in the industry.

Future trends to watch for:

• Impacts of global economic conditions and regulatory changes on pharmaceutical production.
• Advancements in biopharmaceuticals and personalized medicine potentially influencing production dynamics.
• Ongoing effects of the COVID-19 pandemic and emerging health crises on pharmaceutical demand and supply chain stability.